Showing results (1481-1490 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|August 3, 2025
Uncovering the Hidden Hurdles: Exploring Challenges in Pediatric Pharmacovigilance in the NetherlandsAnne T M Dittrich, Yvet Kroeze, Michel A A P Willemsen, et al.
Drug Safety|August 5, 2025
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI InitiativeMelissa Palmer, Daniel Seekins, Mark Avigan, et al.
Drug Safety|June 30, 2025
Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort StudyJoane Titus, Vinay Katukuri, Moheb Boktor, et al.
Drug Safety|June 27, 2025
Temporal Trends of Anticholinergic Drug Exposure Among Older Adults: A 25-Year Population-Based StudyAmanda Evelo, Silvan Licher, Bruno H Stricker, et al.
Drug Safety|June 12, 2025
Investigation of Ochratoxin A and Citrinin Occurrence in Medicinal Herbal Products from the Czech MarketJakub Toman, Darina Pickova, Karolina Brandova, et al.
Drug Safety|March 15, 2025
QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZMona Gerentes, Mohamed Lajnef, Andrei Szöke, et al.
Drug Safety|March 19, 2025
Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Exposed to Glatiramer Acetate Therapy: An Extended 4-Year Safety UpdateSigal Kaplan, Andra Ghimpeteanu, Claudia Florentina Dragut
Drug Safety|April 15, 2025
Investigating Risk of Cancer with Sodium-Glucose Cotransporter 2 Inhibitors: A Disproportionality Analysis in the WHO Global Pharmacovigilance Database Vigibase®Paul Gautier, Meyer Elbaz, Frédéric Bouisset, et al.
Drug Safety|April 10, 2025
Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional StudySharon C M Essink, Inge M Zomerdijk, Sabine M J M Straus, et al.
Drug Safety|June 9, 2023
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series StudyShahab Abtahi, Romin Pajouheshnia, Carlos E Durán, et al.
Pageof 311